KG-1

acute myelogenous leukemia (AML) cell line

Cell Type:
Myeloid (unspec.)
Tissue Origin:
bone marrow
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
SF FF-100 1e6 63-69% 45-53% Plasmid (general) 5 µg 100 µl 4D X-Unit
SF FF-100 2e5 58-62% 47-55% Plasmid (general) 1 µg 20 µl 4D X-Unit
R V-001 2e6 68-72% 77-91% Plasmid (general) 2 µg 100 µl I/II/2b

Citations

Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Albright ER1, Kalejta RF 
In:
J Virol (2013) 87(17): 9802-12 
Categories:
Primary Cells and Media 
Authors:
Ohnishi H, Sasaki H, Nakamura Y, Kato S, Ando K, Narimatsu H, Tachibana K 
In:
Cell Adh Migr (2013) 7(5): 426-33 
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Poole E, McGregor Dallas SR, Colston J, Joseph RS, Sinclair J 
In:
J Gen Virol (2011) 92(7): 1539-49 
Categories:
Transfection 
Authors:
Abbal C, Lambelet M, Bertaggia D, Gerbex C, Martinez M, Arcaro A, Schapira M, Spertini O 
In:
Blood (2006) 108(10): 3352-9